Edaravone: a new hope for deadly amyotrophic lateral sclerosis.
Ranjana Bhandari, Anurag Kuhad, Astha Kuhad
págs. 349-360
Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients.
Jonathan C. Cho, Shyanne C. Locke, A. D. Le
págs. 361-368
Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer.
M Alsharedi, H Bukamur, A Elhamdani
págs. 369-380
Life sciences licensing deals in the first quarter of 2018: updates and trends.
Elisabet Cruces
págs. 381-392
New product intros (avatrombopag maleate, certolizumab pegol [new indication], fostamatinib disodium, GC-1107, sitagliptin phosphate hydrate/ipragliflozin L-proline [new combination], tofacitinib citrate [new indication]).
págs. 393-394
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: